This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Brokers Suggest Investing in Newmont (NEM): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Newmont (NEM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NEMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in CrowdStrike (CRWD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for CrowdStrike (CRWD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for McKesson (MCK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MCKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Toll Brothers (TOL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Toll Brothers (TOL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TOLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Wingstop (WING): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Wingstop (WING) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
WINGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Tutor Perini (TPC) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Tutor Perini (TPC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TPCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Vital Farms (VITL) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VITLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Celsius (CELH) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celsius (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CELHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Agnico (AEM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Agnico (AEM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AEMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Walmart (WMT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Walmart (WMT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WMTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See TJX (TJX) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for TJX (TJX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TJXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Duolingo (DUOL) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Duolingo (DUOL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DUOLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Dell Technologies (DELL) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Dell Technologies (DELL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DELLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in ASML (ASML) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ASML (ASML) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ASMLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Baidu Inc. (BIDU): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Baidu Inc. (BIDU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BIDUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in e.l.f. Beauty (ELF) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ELFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Celestica (CLS) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on The Trade Desk (TTD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for The Trade Desk (TTD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TTDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Nice (NICE): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Nice (NICE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NICEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Roblox (RBLX) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Roblox (RBLX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RBLXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Axon (AXON) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Axon (AXON) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AXONPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think HCI Group (HCI) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCI Group (HCI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HCIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About AutoZone (AZO): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AutoZone (AZO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AZONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Core & Main (CNM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Core & Main (CNM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CNMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth